Mefloquine News and Research

RSS
Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

Laos malaria outbreak in 2020–21 likely caused by multidrug-resistant strains of P. falciparum

Laos malaria outbreak in 2020–21 likely caused by multidrug-resistant strains of P. falciparum

Meta-analysis informs a change to treatment guidelines for uncomplicated malaria in the first trimester of pregnancy

Meta-analysis informs a change to treatment guidelines for uncomplicated malaria in the first trimester of pregnancy

Researchers evaluate artemisinin for COVID-19 management

Researchers evaluate artemisinin for COVID-19 management

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

Anti-malarial drug shows promise in the battle against COVID-19

Anti-malarial drug shows promise in the battle against COVID-19

Study reviews natural drug candidates for potential treatment of COVID-19

Study reviews natural drug candidates for potential treatment of COVID-19

Study identifies a host of agents with anti-SARS-CoV-2 potential

Study identifies a host of agents with anti-SARS-CoV-2 potential

Mefloquine shows potential as anti-SARS-CoV-2 drug

Mefloquine shows potential as anti-SARS-CoV-2 drug

Antimalarials could disrupt SARS-CoV-2’s Nsp1 translation termination

Antimalarials could disrupt SARS-CoV-2’s Nsp1 translation termination

Triple therapies effective and safe in malaria

Triple therapies effective and safe in malaria

Molecular-level understanding of drug interactions could pave way for better malaria treatments

Molecular-level understanding of drug interactions could pave way for better malaria treatments

Artemisinins are still strongest weapon against malaria, say experts

Artemisinins are still strongest weapon against malaria, say experts

Cochrane review provides clarity about safety of mefloquine for preventing malaria in travelers

Cochrane review provides clarity about safety of mefloquine for preventing malaria in travelers

“Super malaria” resistant to standard medications in South East Asia

“Super malaria” resistant to standard medications in South East Asia

Research shows new method for rapidly producing antimalarial drug at industrial scale

Research shows new method for rapidly producing antimalarial drug at industrial scale

TB germs' metabolic 'escape pathways' may be neutralized by new drugs to shorten duration of therapy

TB germs' metabolic 'escape pathways' may be neutralized by new drugs to shorten duration of therapy

Researchers suggest possible novel target for seizure-blocking medicines

Researchers suggest possible novel target for seizure-blocking medicines

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria